Scarica l'app Stockscreener
1.385
6.08%
-0.095
Precedente Chiudi:
$1.48
Aprire:
$1.46
Volume 24 ore:
265.65K
Relative Volume:
0.32
Capitalizzazione di mercato:
$89.46M
Reddito:
$198.53M
Utile/perdita netta:
$-63.68M
Rapporto P/E:
-1.3549
EPS:
-1.0222
Flusso di cassa netto:
$-41.50M
1 W Prestazione:
-5.44%
1M Prestazione:
-31.19%
6M Prestazione:
-81.32%
1 anno Prestazione:
-83.23%
Intervallo 1D:
$1.36
$1.46
Intervallo di 1 settimana:
$1.31
$1.67
Portata 52W:
$1.31
$8.87
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Nome
Treace Medical Concepts Inc
Settore
Industria
Telefono
(904) 373-5940
Indirizzo
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.385 | 95.59M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
110.09 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
342.26 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.89 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.85 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.48 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-07 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-11-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-02-04 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-12-31 | Iniziato | Lake Street | Buy |
| 2024-12-17 | Ripresa | JP Morgan | Neutral |
| 2024-05-16 | Downgrade | UBS | Buy → Neutral |
| 2024-05-08 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-05-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Downgrade | Stifel | Buy → Hold |
| 2024-05-08 | Downgrade | Truist | Buy → Hold |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2023-04-11 | Iniziato | Stephens | Equal-Weight |
| 2022-05-12 | Iniziato | BTIG Research | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Iniziato | JP Morgan | Overweight |
| 2021-05-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Iniziato | SVB Leerink | Outperform |
| 2021-05-18 | Iniziato | Stifel | Buy |
Mostra tutto
Treace Medical Concepts Inc Borsa (TMCI) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Reach Out - ACCESS Newswire
Market Catalysts: Why is Treace Medical Concepts Inc stock going up2025 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Treace Medical Concepts Hits New 52-Week Low at $1.58 - Markets Mojo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 Earnings Call Transcript - Insider Monkey
Treace Medical Concepts (NASDAQ:TMCI) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
TMCI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Treace Medical Earnings Call Balances Progress and Pressure - TipRanks
Lake Street Capital Issues Pessimistic Forecast for Treace Medical Concepts (NASDAQ:TMCI) Stock Price - MarketBeat
Truist Securities Adjusts Treace Medical Concepts PT to $2 From $3, Maintains Hold Rating - marketscreener.com
Treace Medical net loss hits USD 9.4M in Q4 2025 - Medical Buyer
Treace Medical Concepts, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Treace Medical Concepts Q4 Loss Narrowing Challenges Persistent Bearish Narratives On Profitability - Sahm
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Reveals Potential 100% Upside - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect - ACCESS Newswire
Treace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings Results - MarketBeat
Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Is Treace Medical Concepts Inc gaining market shareEarnings Growth Report & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Treace Medical Concepts Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Treace Medical Concepts Q4 2025 reports revenue decline, stock edges up - Investing.com Canada
Treace Medical Concepts Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Treace Medical Concepts earnings missed, revenue topped estimates By Investing.com - Investing.com Canada
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
TREACE MEDICAL CONCEPTS, INC. SEC 10-K Report - TradingView
Treace Medical Concepts: Q4 Earnings Snapshot - marketscreener.com
Treace Medical Concepts (NASDAQ: TMCI) posts 2025 loss and guides flat-to-down 2026 sales - Stock Titan
Treace Medical Concepts Q4 Earnings Summary & Key Takeaways - Benzinga
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results - Bluefield Daily Telegraph
Treace Medical Concepts Q4 2025 Earnings Call Transcript - MarketBeat
Treace Medical Concepts: Fourth Quarter Financial Results Overview - Bitget
Treace Medical Concepts's Earnings: A Preview - Benzinga
Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Report Previ - GuruFocus
Treace Medical Concepts Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Will Treace Medical Concepts Inc. outperform tech stocksJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - mfd.ru
Treace Medical Concepts Unveils Updates to Lapiplasty 3D Bunion Correction System at 2026 ACFAS Conference - geneonline.com
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference - The Globe and Mail
New bunion surgery tools show patients back walking in days - Stock Titan
TMCITreace Medical Concepts, Inc. Latest Stock News & Market Updates - Stock Titan
Treace Medical Concepts (NASDAQ:TMCI) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Upgraded to “Hold” at Wall Street Zen - Defense World
Will Treace Medical Concepts Inc. stock attract more institutional investors2025 Market Outlook & Verified High Yield Trade Plans - mfd.ru
Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Exploring a 118.75% Potential Upside Amidst Healthcare Innovation - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Thursday - MarketBeat
What Catalysts Are Shifting The Narrative For Treace Medical Concepts (TMCI)? - Yahoo Finance
Retail Trends: How much upside does Treace Medical Concepts Inc have2025 Major Catalysts & Weekly Top Gainers Trade List - baoquankhu1.vn
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Treace Medical Concepts to Release Q4 and Full Year 2025 Financial Results - Intellectia AI
Treace Medical Concepts Inc Azioni (TMCI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.61%
1.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):